CD40LG and metabolic dysfunction-associated steatotic liver disease: To determine in which phase in the disease spectrum of NAFLD that plasma IgM titers towards P1 are reduced, participants were divided according to their ALT levels (<25, 25–50, >50 IU/L) because a normal ALT level is expected to be <50 IU/L.